Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale and more continuous clinical data inside hospitals.
The post Danaher Drops $10B to Snatch Masimo in Diagnostics Push appeared first on MedCity News.
